This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Universitè Laval. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Michel Desbiens: Innovator in Bacteriocin Research
Introduction
Michel Desbiens is a notable inventor based in Gaspé, Canada. He has made significant contributions to the field of microbiology, particularly in the development of bacteriocins. His work focuses on innovative solutions to combat microbial proliferation.
Latest Patents
Michel Desbiens holds a patent for a bacteria strain and the bacteriocin produced therefrom. The patent, titled "Bacteria strain and bacteriocin produced therefrom," concerns an isolated bacteriocin known as Divergicin M35. This invention includes a composition that comprises an effective amount of Divergicin M35 and its application in killing or limiting the proliferation of microorganisms. He has 1 patent to his name.
Career Highlights
Desbiens is affiliated with Université Laval, where he conducts research and contributes to advancements in bacteriocin technology. His work has implications for food safety and public health, showcasing the importance of innovative research in microbiology.
Collaborations
Michel Desbiens has collaborated with esteemed colleagues, including Ismail Fliss and Christophe Lacroix. These partnerships enhance the research output and foster a collaborative environment for scientific discovery.
Conclusion
Michel Desbiens is a prominent figure in the field of bacteriocin research, with a focus on innovative solutions to microbial challenges. His contributions through patents and collaborations highlight the importance of research in advancing public health and safety.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile